Science Daily — North Central Cancer Treatment Group (NCCTG) researchers, based at Mayo Clinic in Rochester, Minn., have generated preliminary data suggesting that a form of American ginseng provides greater improvements in fatigue and vitality in patients who receive the highest doses tested, compared to lower doses or no treatment.
American ginseng. (Credit: iStockphoto/Mike Liu)
The results of their scientifically rigorous pilot study, the first to evaluate the Wisconsin species of American ginseng as a possible therapy for cancer-related fatigue, were presented June 3 at the annual meeting of the American Society of Clinical Oncology.
This press release goes on to explain how most Americans don't pick their herbs and supplements based upon scientific research. So with this study they are trying to shed some light. I Look forward to the full study. Of course those uniformed folks could always ask an expert. Send me an email. I'll answer it. Alex
